Comparison between Owais Metal IPO and Zenith Drugs IPO.
Owais Metal IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
| Owais Metal IPO | Zenith Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Owais Metal IPO is up to ₹39.70 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Owais Metal IPO is ₹87.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
| Owais Metal IPO | Zenith Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹83.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹87.00 per share | ₹79.00 per share |
| Issue Price (Final) | ₹87.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 45,63,200 shares | 42,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹39.70 Cr | up to ₹33.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 45,63,200 shares | 42,96,000 shares |
| Issue Size Total (Amount) | up to ₹39.70 Cr | up to ₹33.94 Cr |
Owais Metal IPO opens on Feb 26, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Owais Metal IPO and Zenith Drugs IPO is Feb 28, 2024, and Feb 22, 2024, respectively.
| Owais Metal IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Feb 23, 2024 | Feb 16, 2024 |
| Issue Open | Feb 26, 2024 | Feb 19, 2024 |
| Issue Close | Feb 28, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Feb 29, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Mar 01, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Mar 01, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Mar 04, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | Mar 30, 2024 | Mar 24, 2024 |
| Anchor Lockin End date 2 | May 29, 2024 | May 23, 2024 |
Owais Metal IPO P/E ratio is 21.35, as compared to Zenith Drugs IPO P/E ratio of 18.4.
| Owais Metal IPO | Zenith Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Owais Metal and Mineral Processing Limited Financial Information (Restated)
| Zenith Drugs Limited Financial Information (Restated Consolidated)Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.01 | 69.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.35 | 18.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹158.19 Cr. | ₹135.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | -5.35% | 35.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.29% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.61 | 1.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.08 | ₹4.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -22.22% | 29.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Owais Metal IPO Retail Individual Investors (RII) are offered 15,98,400 shares while in Zenith Drugs IPO retail investors are offered 15,98,400 shares. Qualified Institutional Buyers (QIB) are offered 9,12,000 shares in Owais Metal IPO and 8,59,200 shares in Zenith Drugs IPO.
| Owais Metal IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Investor Reserveration | 13,68,000 shares | 12,88,000 shares |
| Market Maker Reserveration | 3,44,000 shares | 8,52,800 shares |
| QIB | 9,12,000 shares | 8,59,200 shares |
| NII | 6,84,800 shares | 6,44,800 shares |
| RII | 15,98,400 shares | 15,04,000 shares |
| Employee | ||
| Others | ||
| Total | 45,63,200 shares | 42,96,000 shares |
Owais Metal IPO subscribed 221.18x in total, whereas Zenith Drugs IPO subscribed 179.18x.
| Owais Metal IPO | Zenith Drugs IPO | |
|---|---|---|
| QIB (times) | 92.06x | 106.72x |
| NII (times) | 329.36x | 368.77x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 248.50x | 139.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 221.18x | 179.18x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
